COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-733.
2. WHO Novel Coronavirus (2019-nCoV) situation report-1. 21 January 2020. https://www.who.int/docs/default-source/coronaviruse/situationreports/ 20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4
3. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) https://www.who.int/docs/default-source/coronaviruse/whochina- joint-mission-on-covid-19-final-report.pdf
4. World Health Organization. Origin of SARS-CoV-2 (26 March 2020) https:// www.who.int/health-topics/coronavirus/who-recommendations-to-reducerisk-of-transmission-of-emerging-pathogens-from-animals-to-humans-inlive- animal-markets
5. Coronavirus disease (COVID-2019) situation reports. https://www.who. int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73- covid-19.pdf?sfvrsn=5ae25bc7_2
6. Türkiye’de 2020 koronavirüs pandemisi. https://tr.wikipedia.org/wiki/ Türkiye%27de_2020_koronavirüs_pandemisi#cite_note-1Nisan-59
7. Habibzadeh P, Stoneman EK. The Novel Coronavirus: A Bird’s Eye View. Int J Occup Environ Med. 2020;11:65-71.
8. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24:490-502.
9. Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocul Immunol Inflamm. 2020;16:1-5.
10. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221-236.
11. Lu R, Zhao X, Li J, Niu P, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020:22;395:565-574.
12. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
13. Chen NS, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020:15;395:507-513.
14. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS. China Medical Treatment Expert Group for Covid- 19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb 28.
15. Laboratory testing of 2019 novel coronavirus (2019-nCoV)in suspected human cases: interim guidance, 17 January 2020. https://apps.who.int/iris/bitstream/ handle/10665/330676/9789240000971-eng.pdf?sequence=1&isAllowed=y
16. World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Interim guidance, 2020 https://www.who.int/publications-detail/infection-prevention-andcontrol- during-health-care-when-novel-coronavirus-(ncov)-infection-issuspected- 20200125
17. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020:20;9:19.
18. Yan A. Chinese expert who came down with Wuhan coronavirus after saying it was controllable thinks he was infected through his eyes China: South China morning post. https://www.scmp.com/news/china/article/3047394/chineseexpert- who-came-downwuhan-coronavirus-after-saying-it-was. 2020.
19. Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol. 2020 Mar 3. doi:10.1007/s00417-020-04641-8.
20. Lu CW, Liu XF & Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395:e39.
21. Li JO, Lam DSC, Chen Y, Ting DSW. Novel Coronavirus disease 2019 (COVID- 19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020;104:297-298.
22. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B. Identification of a new human coronavirus. Nat Med. 2004;10:368-373.
23. Vabret A, Mourez T, Dina J, van der Hoek L, Gouarin S, Petitjean J, Brouard J, Freymuth F. Human coronavirus NL63, France. Emerg Infect Dis. 2005;11:1225-1229.
24. Loon S-C, Teoh SCB, Oon LLE, Se-Thoe SY, Ling AE, Leo YS, Leong HN. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88:861-863.
25. Chan WM, Yuen KS, Fan DS, Lam DS, Chan PK, Sung JJ. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br J Ophthalmol. 2004;88:968-969.
26. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020 Feb 26. doi: 10.1002/jmv.25725.
27. Jun ISY, Anderson DE, Kang AEZ, et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology 2020 in Press. https://doi.org/10.1016/j.ophtha.2020.03.026
28. Seitzman GD, Doan T. No time for tears. Ophthalmology 2020, doi: https:// doi.org/10.1016/j.ophtha.2020.03.030
29. Choudhary R, Kapoor MS, Singh A & Bodakhe SH (2017): Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2017;29:7-16.
30. Qing H, Li Z, Yang Z, Shi M, Huang Z, Song J, Song Z. The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol. 2020 Mar 18. doi: 10.1111/aos.14412.
31. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine. 2020.
32. American Academy of Ophthalmology. Alert: Important coronavirus updates for ophthalmologists. https://www.aao.org/headline/alert-importantcoronavirus- context
33. Junk AK, Chen PP, Lin SC, Nouri-Mahdavi K, Radhakrishnan S, Singh K, Chen TC. “Disinfection of Tonometers: A Report By the American Academy of Ophthalmology.” Ophthalmology. 2017;124:1867-1875.
34. Marmor MF. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern? AJOPHT11279_proof, 24 March 2020
35. Devaux CA, Rolain J-M, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents 2020;11:105938.
36. Marmor M, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123:1386-1394.
37. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label nonrandomized clinical trial. Int J Antimicrob Agents. 2020;20:105949.
38. COVID-19. Teması olan Sağlık Çalışanlarının Değerlendirilmesi. https:// ohsad.org/wp-content/uploads/2020/03/COVID19-TemasiOlanSaglikCalisan larininDegerlendirilmesi-25032020.pdf.pdf
39. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği. Klorokin ve Hidroksiklorokinin COVID-19 Hastalarında ve Hastalığın Profilaksisinde Kullanımı Konusunda KLİMİK Derneği Görüşü. 21 Mart 2020 [Erişim Tarihi: 22 Mart 2020]. https://www.klimik.org.tr/koronavirus/klorokinve- hidroksiklorokinin-covid-19-hastalarinda-ve-hastaligin-profilaksisindekullanimi- konusunda-klimik-dernegi-gorusu/
40. COVID-19 Erişkin Hasta Tedavisi. https://covid19bilgi.saglik.gov.tr/depo/ tedavi/COVID19_Eriskin_Hasta_Tedavisi_02042020.pdf
41. COVID-19 Çocuk Hasta Yönetimi ve Tedavisi. https://covid19bilgi.saglik. gov.tr/depo/tedavi/COVID19-_Cocuk_Hasta_Yonetimi_ve_Tedavisi.pdf

APA	Bozkurt B, Egrilmez S, Şengör T, YILDIRIM G, İRKEÇ M (2020). COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. , 59 - 63. 10.4274/tjo.galenos.2020.29805
Chicago	Bozkurt Banu,Egrilmez Sait,Şengör Tomris,YILDIRIM Gül Özlem,İRKEÇ Murat T. COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. (2020): 59 - 63. 10.4274/tjo.galenos.2020.29805
MLA	Bozkurt Banu,Egrilmez Sait,Şengör Tomris,YILDIRIM Gül Özlem,İRKEÇ Murat T. COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. , 2020, ss.59 - 63. 10.4274/tjo.galenos.2020.29805
AMA	Bozkurt B,Egrilmez S,Şengör T,YILDIRIM G,İRKEÇ M COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. . 2020; 59 - 63. 10.4274/tjo.galenos.2020.29805
Vancouver	Bozkurt B,Egrilmez S,Şengör T,YILDIRIM G,İRKEÇ M COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. . 2020; 59 - 63. 10.4274/tjo.galenos.2020.29805
IEEE	Bozkurt B,Egrilmez S,Şengör T,YILDIRIM G,İRKEÇ M "COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme." , ss.59 - 63, 2020. 10.4274/tjo.galenos.2020.29805
ISNAD	Bozkurt, Banu vd. "COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme". (2020), 59-63. https://doi.org/10.4274/tjo.galenos.2020.29805

APA	Bozkurt B, Egrilmez S, Şengör T, YILDIRIM G, İRKEÇ M (2020). COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. Türk Oftalmoloji Dergisi, 50(2), 59 - 63. 10.4274/tjo.galenos.2020.29805
Chicago	Bozkurt Banu,Egrilmez Sait,Şengör Tomris,YILDIRIM Gül Özlem,İRKEÇ Murat T. COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. Türk Oftalmoloji Dergisi 50, no.2 (2020): 59 - 63. 10.4274/tjo.galenos.2020.29805
MLA	Bozkurt Banu,Egrilmez Sait,Şengör Tomris,YILDIRIM Gül Özlem,İRKEÇ Murat T. COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. Türk Oftalmoloji Dergisi, vol.50, no.2, 2020, ss.59 - 63. 10.4274/tjo.galenos.2020.29805
AMA	Bozkurt B,Egrilmez S,Şengör T,YILDIRIM G,İRKEÇ M COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. Türk Oftalmoloji Dergisi. 2020; 50(2): 59 - 63. 10.4274/tjo.galenos.2020.29805
Vancouver	Bozkurt B,Egrilmez S,Şengör T,YILDIRIM G,İRKEÇ M COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme. Türk Oftalmoloji Dergisi. 2020; 50(2): 59 - 63. 10.4274/tjo.galenos.2020.29805
IEEE	Bozkurt B,Egrilmez S,Şengör T,YILDIRIM G,İRKEÇ M "COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme." Türk Oftalmoloji Dergisi, 50, ss.59 - 63, 2020. 10.4274/tjo.galenos.2020.29805
ISNAD	Bozkurt, Banu vd. "COVID-19 Salgını: Göz Hekimlerine Yönelik Klinik Bilgilendirme". Türk Oftalmoloji Dergisi 50/2 (2020), 59-63. https://doi.org/10.4274/tjo.galenos.2020.29805